Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Clinical Trials
100%
Acetylcholinesterase Inhibitors (AChEI)
100%
Vascular Dementia
100%
Alzheimer's Disease
75%
Cerebrovascular Disease
75%
Ischemia
25%
Controlled Experiment
25%
Pathogenic Mechanism
25%
Cardiovascular Disease
25%
Cholinergic Dysfunction
25%
Causes of Dementia
25%
Activities of Daily Living
25%
Common Cause
25%
Cognitive Loss
25%
Promising Treatment
25%
Vascular Cognitive Impairment
25%
Basal Forebrain
25%
Cognitive Decline
25%
Donepezil
25%
Cholinergic Pathway
25%
Rivastigmine
25%
Ischemic Brain Injury
25%
Galantamine
25%
Inhibitor Agent
25%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Cholinesterase Inhibitor
100%
Multiinfarct Dementia
100%
Alzheimer's Disease
75%
Cerebrovascular Disease
75%
Cholinergic Receptor Stimulating Agent
50%
Cardiovascular Disease
25%
Ischemia
25%
Controlled Clinical Trial
25%
Cognitive Defect
25%
Donepezil
25%
Brain Injury
25%
Rivastigmine
25%
Galantamine
25%
Neuroscience
Vascular Dementia
100%
Acetylcholinesterase Inhibitor
100%
Alzheimer's Disease
75%
Cerebrovascular Disease
75%
Cholinergic
50%
Behavior (Neuroscience)
25%
Ischemia
25%
Basal Forebrain
25%
Cognitive Disorder
25%
Donepezil
25%
Rivastigmine
25%
Galantamine
25%
Nucleus
25%